Concepedia

Sofosbuvir/velpatasvir improves patient-reported outcomes in HCV patients: Results from ASTRAL-1 placebo-controlled trial

Zobair M. Younossi, Maria Stepanova, Jordan J. Feld, Stefan Zeuzem, Ira M. Jacobson, Kosh Agarwal, Christophe Hézode, Fatema Nader, Linda Henry, Sharon Hunt

Journal of Hepatology · 2016 · 112 citations · 38 references

DOI

Concepts

References

38

The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument

Margaret C. Reilly, Arthur S. Zbrozek, Ellen Dukes · PharmacoEconomics · 1993 · 3.1K citations

, , +13

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

Nezam H. Afdhal, Stefan Zeuzem, Paul Y. Kwo et al. · New England Journal of Medicine · 2014 · 1.7K citations · Full text

, , +17

Summary of notifiable diseases--United States, 2012.

Deborah A. Adams, Ruth Ann Jajosky, Umed A. Ajani et al. · PubMed · 2014 · 1.3K citations

, , +15

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

Nezam H. Afdhal, K. Rajender Reddy, David R. Nelson et al. · New England Journal of Medicine · 2014 · 1.3K citations

, , +12

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

Kris V. Kowdley, Stuart C. Gordon, K. Rajender Reddy et al. · New England Journal of Medicine · 2014 · 1.1K citations · Full text

, , +13